{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:54:44Z","timestamp":1790664884393,"version":"4.1.0"},"reference-count":61,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Folliculitis decalvans (FD) and dissecting cellulitis of the scalp (DCS) are neutrophilic primary cicatricial alopecias characterized by chronic inflammation and irreversible hair loss, with distinct pathogenic mechanisms that make accurate diagnosis essential for appropriate management. This narrative review aims to provide a comprehensive overview of systemic therapeutic options for FD and DCS, to evaluate their efficacy in relation to underlying disease mechanisms, and to explore emerging targeted treatments. A literature search was conducted in PubMed\/MEDLINE using relevant keywords related to neutrophilic cicatricial alopecias and therapeutic strategies, including studies reporting clinical outcomes in FD and DCS. Available evidence indicates that conventional therapies remain the cornerstone of management: antibiotics are typically first-line in FD, while isotretinoin represents the mainstay of treatment in DCS and a key option in refractory FD; however, these approaches are often associated with partial responses and frequent relapses. Biologic agents, particularly TNF-\u03b1 inhibitors, have shown consistent benefit in refractory cases, while IL-17\/23 and JAK inhibitors are supported by limited but emerging data. Overall, treatment response appears to reflect underlying pathogenic differences between FD and DCS, underscoring the importance of a tailored, mechanism-based approach. Further studies are needed to establish standardized treatment algorithms and confirm long-term efficacy and safety.<\/jats:p>","DOI":"10.3390\/life16050835","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:33:54Z","timestamp":1779687234000},"page":"835","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets"],"prefix":"10.3390","volume":"16","author":[{"given":"Francesca","family":"Svara","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Bortone","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-7709","authenticated-orcid":false,"given":"Luca","family":"Ambrosio","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"},{"name":"Istituto Dermopatico dell\u2019Immacolata (IDI-IRCCS), Dermatological Research Hospital, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0118-1965","authenticated-orcid":false,"given":"Felice","family":"Forte","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0727-8314","authenticated-orcid":false,"given":"Luca","family":"Gargano","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9504-5882","authenticated-orcid":false,"given":"Annunziata","family":"Dattola","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3828-0883","authenticated-orcid":false,"given":"Steven Paul","family":"Nistic\u00f2","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pellacani","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2181-951X","authenticated-orcid":false,"given":"Carmen","family":"Cantisani","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medical and Cardiovascular Sciences, \u201cSapienza\u201d University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000467395","article-title":"Primary Scarring Alopecia: Clinical-Pathological Review of 72 Cases and Review of the Literature","volume":"3","author":"Villablanca","year":"2017","journal-title":"Ski. Appendage Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0738-081X(00)00132-2","article-title":"Cicatricial alopecia: Clinico-pathological findings and treatment","volume":"19","author":"Whiting","year":"2001","journal-title":"Clin. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1067\/mjd.2003.68","article-title":"Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001","volume":"48","author":"Olsen","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jaad.2023.04.023","article-title":"Treatment modalities for lymphocytic and neutrophilic scarring alopecia","volume":"89","author":"Ezemma","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cummins, D.M., Chaudhry, I.H., and Harries, M. (2021). Scarring Alopecias: Pathology and an Update on Digital Developments. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121755"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/jdv.20687","article-title":"Management of folliculitis decalvans: The EADV task force on hair diseases position statement","volume":"39","author":"Starace","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s13555-023-01018-7","article-title":"Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm","volume":"13","author":"Masson","year":"2023","journal-title":"Dermatol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jaad.2015.01.056","article-title":"Primary cicatricial alopecia: Other lymphocytic primary cicatricial alopecias and neutrophilic and mixed primary cicatricial alopecias","volume":"75","author":"Bolduc","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e70197","DOI":"10.1111\/exd.70197","article-title":"Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?","volume":"35","author":"Awad","year":"2026","journal-title":"Exp. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1468-3083.2012.04530.x","article-title":"Dermoscopy guided scalp biopsy in cicatricial alopecia","volume":"27","author":"Miteva","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamadermatol.2025.3540","article-title":"Approach to Scarring Alopecia","volume":"161","author":"Wyche","year":"2025","journal-title":"JAMA Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"adv44185","DOI":"10.2340\/actadv.v105.44185","article-title":"Treatment Survival and Reasons for Discontinuation in Patients with Recalcitrant Folliculitis Decalvans","volume":"105","author":"Farnina","year":"2025","journal-title":"Acta Derm. Venereol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/ijabmr.ijabmr_414_24","article-title":"Folliculitis Decalvans: An Uncommon Case Report with Review of Literature","volume":"15","author":"Singh","year":"2025","journal-title":"Int. J. Appl. Basic Med. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jaad.2020.10.073","article-title":"Folliculitis decalvans microbiologic signature is specific for disease clinical phenotype","volume":"85","author":"Paoli","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_15","first-page":"e52881","article-title":"Successful Management of Folliculitis Decalvans","volume":"16","author":"Kashikar","year":"2024","journal-title":"Cureus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/jdv.12993","article-title":"Folliculitis decalvans: A multicentre review of 82 patients","volume":"29","author":"Barco","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/jdv.13052","article-title":"Oral isotretinoin as the most effective treatment in folliculitis decalvans: A retrospective comparison of different treatment regimens in 28 patients","volume":"29","author":"Tietze","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e14051","DOI":"10.1111\/dth.14051","article-title":"Lymecycline as a treatment option for dissecting cellulitis and folliculitis decalvans","volume":"33","author":"Melo","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_19","first-page":"e60633","article-title":"Effective Treatment of Folliculitis Decalvans with a Combination of Oral Isotretinoin and Rifampicin","volume":"16","author":"Jawade","year":"2024","journal-title":"Cureus"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ijd.13874","article-title":"Isotretinoin treatment for folliculitis decalvans: A retrospective case-series study","volume":"57","author":"Aksoy","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"adv12373","DOI":"10.2340\/actadv.v104.12373","article-title":"Clinical Characterization and Treatment Response of Folliculitis Decalvans Lichen Planopilaris Phenotypic Spectrum: A Unicentre Retrospective Series of 31 Patients","volume":"104","year":"2024","journal-title":"Acta Derm. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/ced\/llae394","article-title":"Hydroxychloroquine may be beneficial as an adjuvant therapy for folliculitis decalvans: A 5-year retrospective study with 49 patients","volume":"50","author":"Doche","year":"2025","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1111\/ajd.13532","article-title":"Effective treatment of folliculitis decalvans with cyclosporin: A case series","volume":"62","author":"Jerjen","year":"2021","journal-title":"Australas. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaad.2021.07.004","article-title":"Topical dapsone for folliculitis decalvans: A retrospective cohort study","volume":"87","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/ijd.17136","article-title":"Carbon-dioxide laser-associated PDT treatment of folliculitis decalvans","volume":"63","author":"Varga","year":"2024","journal-title":"Int. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102356","DOI":"10.1016\/j.pdpdt.2021.102356","article-title":"Photodynamic therapy should be considered for the treatment of folliculitis decalvans","volume":"35","author":"Yang","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/ced.13238","article-title":"Systemic photodynamic therapy in folliculitis decalvans","volume":"43","author":"Collier","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_28","first-page":"1152","article-title":"Nd:YAG laser treatment of recalcitrant folliculitis decalvans","volume":"30","author":"Parlette","year":"2004","journal-title":"Dermatol. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdcr.2021.04.008","article-title":"The role of platelet-rich plasma therapy in refractory folliculitis decalvans","volume":"12","author":"Suh","year":"2021","journal-title":"JAAD Case Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.12788\/cutis.1023","article-title":"Recalcitrant Folliculitis Decalvans Treatment Outcomes with Biologics and Small Molecule Inhibitors","volume":"113","author":"Fakhoury","year":"2024","journal-title":"Cutis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e8193","DOI":"10.1002\/ccr3.8193","article-title":"Folliculitis decalvans managed with adalimumab: A case report","volume":"11","author":"Alsantali","year":"2023","journal-title":"Clin. Case Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"adv3713","DOI":"10.2340\/actadv.v103.3713","article-title":"Efficacy and Safety of Tumour Necrosis Factor-\u03b1 Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study","volume":"103","author":"Dupont","year":"2023","journal-title":"Acta Derm. Venereol."},{"key":"ref_33","first-page":"e15778","article-title":"Refractory folliculitis decalvans treated with biologics: Case series in 4 situations","volume":"35","author":"Pujol","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/ijd.15914","article-title":"Therapy-refractory folliculitis decalvans treated with certolizumab pegol","volume":"61","author":"Hoy","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaad.2022.02.044","article-title":"Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients","volume":"87","author":"Iorizzo","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/ced\/llae421","article-title":"Evidence of interleukin-17-secreting mast cells in scalp lesions of folliculitis decalvans points to new therapeutic targets in recalcitrant lesions","volume":"50","author":"Franciozi","year":"2025","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/ajd.13190","article-title":"Successful treatment of refractory folliculitis decalvans with secukinumab","volume":"61","author":"Ismail","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ajd.13786","article-title":"Successful treatment of folliculitis decalvans with baricitinib: A case series","volume":"63","author":"Moussa","year":"2022","journal-title":"Australas. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/ijd.70084","article-title":"Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors","volume":"64","author":"Gallo","year":"2025","journal-title":"Int. J. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jdcr.2024.10.036","article-title":"Response to F\u00e4ssler et al\u2019s \u201cSuccessful treatment of refractory folliculitis decalvans with apremilast\u201d","volume":"57","author":"Dethier","year":"2025","journal-title":"JAAD Case Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jdcr.2024.12.001","article-title":"Response to Dethier et al, \u201cExperience in nine additional cases of apremilast for therapy-resistant folliculitis decalvans\u201d","volume":"57","author":"Jafari","year":"2025","journal-title":"JAAD Case Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40268-020-00335-y","article-title":"Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis","volume":"21","author":"Guo","year":"2021","journal-title":"Drugs R&D"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00403-020-02152-4","article-title":"Oral isotretinoin for the treatment of dermatologic conditions other than acne: A systematic review and discussion of future directions","volume":"313","author":"Chu","year":"2021","journal-title":"Arch. Dermatol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e14829","DOI":"10.1111\/dth.14829","article-title":"The role of biologic treatment in special scenarios in hidradenitis suppurativa: Facial and nape phenotype, dissecting cellulitis of the scalp, and lymphedema","volume":"34","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_45","first-page":"115","article-title":"Determinant factors of biological therapy for dissecting cellulitis of the scalp","volume":"22","author":"Ramos","year":"2024","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/ced\/llad036","article-title":"Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: A retrospective multicentre study","volume":"48","author":"Alzahrani","year":"2023","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(24)02475-9","article-title":"Hidradenitis suppurativa","volume":"405","author":"Sabat","year":"2025","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ajd.13860","article-title":"Treatment of dissecting cellulitis of the scalp with Tildrakizumab","volume":"63","author":"Awad","year":"2022","journal-title":"Australas. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13023-025-03720-5","article-title":"A systematic review of tumor necrosis factor-\u03b1 blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment","volume":"20","author":"Heidari","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_50","first-page":"005743","article-title":"Janus kinase inhibitors as a breakthrough treatment for refractory dissecting cellulitis of the scalp","volume":"12","author":"Sayed","year":"2025","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_51","first-page":"e52377","article-title":"Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib","volume":"16","author":"Islam","year":"2024","journal-title":"Cureus"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.2147\/JIR.S504393","article-title":"Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib","volume":"18","author":"Qiu","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e24092","DOI":"10.1097\/MD.0000000000024092","article-title":"Surgical management of dissecting cellulitis of the scalp using free latissimus dorsi flap and meshed split-thickness skin graft: A case report","volume":"100","author":"Baneu","year":"2021","journal-title":"Medicine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1308\/rcsann.2020.7096","article-title":"Severe dissecting scalp cellulitis successfully treated with serial excisions in combination with anti-TNF therapy","volume":"103","author":"Spiers","year":"2021","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40257-026-01028-z","article-title":"Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances","volume":"27","author":"Valtellini","year":"2026","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.det.2021.03.004","article-title":"Central Centrifugal Cicatricial Alopecia: Challenges and Treatments","volume":"39","author":"Lawson","year":"2021","journal-title":"Dermatol. Clin."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/12034754221126118","article-title":"Acne Keloidalis Nuchae","volume":"26","author":"Alves","year":"2022","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Katoulis, A.C., Pappa, G., Sgouros, D., Markou, E., Kanelleas, A., Bozi, E., Ioannides, D., and Rudnicka, L. (2025). A Three-Step Diagnostic Algorithm for Alopecia: Pattern Analysis in Trichoscopy. J. Clin. Med., 14.","DOI":"10.3390\/jcm14041195"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1529-8019.2008.00204.x","article-title":"Folliculitis decalvans","volume":"21","author":"Otberg","year":"2008","journal-title":"Dermatol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaad.2020.03.092","article-title":"Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series","volume":"85","author":"Uchiyama","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_61","first-page":"1219","article-title":"Dissecting folliculitis (dissecting cellulitis) of the scalp: A 66-patient case series and proposal of classification","volume":"16","author":"Lee","year":"2018","journal-title":"JDDG J. Dtsch. Dermatol. Ges."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/5\/835\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:53:41Z","timestamp":1779688421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/5\/835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["life16050835"],"URL":"https:\/\/doi.org\/10.3390\/life16050835","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}